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ABSTRACT
Thymocyte differentiation is a complex process
involving well-defined sequential developmental
stages that ultimately result in the generation of ma-
ture T-cells. In this study, we analyzed DNA methyla-
tion and gene expression profiles at successive hu-
man thymus developmental stages. Gain and loss of
methylation occurred during thymocyte differentia-
tion, but DNA demethylation was much more frequent
than de novo methylation and more strongly cor-
related with gene expression. These changes took
place in CpG-poor regions and were closely associ-
ated with T-cell differentiation and TCR function. Up
to 88 genes that encode transcriptional regulators,
some of whose functions in T-cell development are
as yet unknown, were differentially methylated dur-
ing differentiation. Interestingly, no reversion of ac-
cumulated DNA methylation changes was observed
as differentiation progressed, except in a very small
subset of key genes (RAG1, RAG2, CD8A, PTCRA,
etc.), indicating that methylation changes are mostly
unique and irreversible events. Our study explores
the contribution of DNA methylation to T-cell lym-
phopoiesis and provides a fine-scale map of differ-
entially methylated regions associated with gene ex-
pression changes. These can lay the molecular foun-
dations for a better interpretation of the regulatory
networks driving human thymopoiesis.
INTRODUCTION
Hematopoiesis is a hierarchical process that facilitates the
generation of exceptionally great cellular diversity from a
single progenitor. In order to fulfill this complex devel-
opmental program, multipotent progenitors must transit
across various intermediate progenitor stages and be able
to deploy a flexible transcriptional program. T-cell differ-
entiation is initiated from bone marrow-derived progeni-
tors that colonize the thymus. These early thymic immi-
grants are still uncommitted and can differentiate into mul-
tiple hematopoietic lineages, namely, B and T lymphocytes,
NK cells and myeloid cells (1–3). The first restricted T-cell
population (CD34+CD1a+) expressed neither a functional
T-cell receptor (TCR) nor the CD4 and CD8 coreceptors
(4,5). Rearrangements of the TCRD, TCRGandTCRB loci
are initiated at this stage (6,7), and  T-cell differentiation
progresses toward double positive (DP) thymocytes via an
immature single positive (ISP) CD4+ stage. Only DP thy-
mocytes that have successfully rearranged TCRB and ex-
press a TCR chain in associationwith the pre-TCR chain
can progress further, proliferate and undergo TCRA gene
rearrangements, in a process termed -selection. Once the
mature TCR is expressed, DP thymocytes become posi-
tively selected and mature into CD4+ or CD8+ single pos-
itive (SP) cells that finally leave the thymus and migrate to
the periphery.
While thymocyte maturation is a very complex process,
it is commonly accepted that differentiation of an early
uncommitted progenitor into a mature T lymphocyte is
a unidirectional and sequential process that involves first
the loss of multipotency and then the acquisition of the
highly specialized T-cell function (8). The molecular mech-
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anisms that contribute to these processes are of particu-
lar interest. T-cell development is critically dependent on
unique stepwise signals provided by NOTCH1, although
a highly complex transcriptional network encompasses the
differentiation process at each developmental stage. In fact,
NOTCH1 signaling, together with some driving factors,
such as RUNX1, GATA3, LEF1, IKAROS and c-MYC,
induce T-cell commitment and enable T-cell maturation
(9–12). In addition, these transcriptional modulators must
work in conjunction with cis-regulatory elements and then
contribute to the regulation of targeted genes at each dif-
ferentiation stage. Unfortunately, the mechanistic details
of these interactions are largely unknown. Recent evidence
from mouse thymocytes showed that histone modifications
act as highly dynamic cis-regulatory elements closely related
to gene expression and transcription factor binding dur-
ing T-cell development (13,14). For instance, PU.1 binding
to the Tal1 gene during thymocyte differentiation is associ-
ated with enriched dimethylation at lysine 4 of histone H3
(H3K4me2) and increased gene expression, but inversely
correlated with trimethylation of lysine 27 of histone H3
(H3K27me3) (13). In addition to histone marking, other
epigenetic mechanisms, such as DNA methylation, which
is usually associated with gene repression, can also play a
key role in T-cell development. Indeed, DNA methylation
analysis of DN1, DN2 and DN3 mouse thymocytes have
identified some differentially methylated genes that are es-
sential during thymopoiesis, including genes encoding the
lymphocyte-specific protein tyrosine kinase (Lck) and tran-
scription factor 7 (Tcf7) (15). Changes in DNAmethylation
patterns are likewise essential for the induction of T-cell ef-
fector functions and T-cell plasticity and affect key genes
such as IFNG, FOXP3, GZMB and RORC (16–22), further
highlighting the importance of the role ofDNAmethylation
in the acquisition and maintenance of T-cell identity.
In this study, we sought to explore the association of
particular DNA methylation profiles with the highly dy-
namic transcriptional program encompassing human  T-
cell differentiation, from early uncommitted progenitors to
intrathymic SP CD4+ and SP CD8+ populations. Our anal-
ysis revealed a global trend of demethylation during T-cell
differentiation that was closely associated with the develop-
ment of the TCR function. This provides new insights into
the regulatory mechanisms involved in the process.
MATERIALS AND METHODS
Isolation of human thymocyte subpopulations
Thymus samples were routinely obtained during pediatric
corrective cardiac surgery. Informed consent was obtained
in accordance with the Declaration of Helsinki. The study
was performed in accordance with approved guidelines es-
tablished by the Research Ethics Board of the Spanish
Research Council. Normal human postnatal thymocytes
were isolated by Ficoll-Hypaque centrifugation (Nycomed,
Pharma) from thymus fragments removed during correc-
tive cardiac surgery of patients aged 1 month to 4 years.
CD34+ intrathymic progenitors were isolated from thymo-
cyte suspensions by depletion of mature thymocytes us-
ing a sheep red blood cell rosetting technique (23), fol-
lowed by immunomagnetic cell sorting using the Dynal
CD34 Progenitor Cell Selection System (Life Technolo-
gies), according to the manufacturer’s instructions. CD34+-
selected cells were then depleted of CD4+ thymocytes by
AutoMACS cell sorting using CD4 MicroBeads (Miltenyi
Biotec). This population was subjected to further treatment
with CD1a MicroBeads and magnetic cell sorting (Au-
toMACS), as described elsewhere (7). This produced two
separate populations of CD34int CD1a+ thymocyte precur-
sors and CD34bright CD1a− multipotent progenitors, which
are referred to throughout this paper as CD34+ CD1a+ and
CD34+ CD1a−, respectively.
To isolate pre-TCR+ thymocytes, cell suspensions ob-
tained by Ficoll-Hypaque were fractionated by centrifu-
gation on stepwise Percoll density gradients (Pharmacia,
LKB), as described elsewhere (7). Thymocytes recovered
from the 1.068 density layer were first depleted of mature T-
cells by incubation with phycoerythrin-labeled anti-TCR
plus anti-TCR mAbs (Beckman Coulter) and anti-PE
MicroBeads (Miltenyi Biotec), followed by two rounds of
AutoMACS negative selection. Next, pre-TCR thymocytes
were isolated by positive selection using CD8 MicroBeads
(Miltenyi Biotec), as previously described (24).
To isolate DP TCR+ thymocytes, CD4+ cells were first
selected from cell suspensions obtained by Ficoll-Hypaque
centrifugation by magnetic sorting using the CD4 Multi-
Sort Kit (Miltenyi Biotec). CD8+ cells were then magneti-
cally sorted from the recovered CD4+ cell subset using the
CD8MultiSort Kit (Miltenyi Biotec), and the CD4+ CD8+
(DP) cell fraction was then subjected to treatment with a
PE-labeled anti-TCR mAb (Beckman Coulter), anti-PE
MicroBeads (Miltenyi Biotec) and magnetic cell sorting to
yield the DP TCR+ cell subset.
CD4+ and CD8+ SP thymocytes were independently iso-
lated from Ficoll-Hypaque thymocyte suspensions. Cells
were first subjected to two rounds of depletion using CD8
or CD4 MicroBeads, and recovered cells depleted of CD4+
or CD8+ thymocytes were treated with CD8 or CD4 Mi-
croBeads, respectively, and positively selected by magnetic
sorting. CD4− CD8+- and CD4+ CD8−-sorted popula-
tions were then incubated with PE-coupled anti-TCR
and anti-PE MicroBeads and subjected to positive selec-
tion. Isolated cell subsets were >95% pure for the indicated
phenotype upon fluorescence-activated cell sorting (FACS)
reanalysis (Supplementary Figure S1).
RNA extraction, whole genome gene expression characteri-
zation and quantitative real-time PCR
Total RNA was isolated with an RNAqueous-Micro kit
(Ambion). RNA integrity, size and quantificationwere eval-
uated in RNA Nano Chips with a Bioanalyzer (Agilent
Technologies) and Qubit R© 2.0 Fluorometer (Life Tech-
nologies). Whole-genome expression was characterized us-
ing Human HT12 v4 BeadChips (Illumina Inc.). In brief,
cRNA was synthesized with a TargetAmpTM Nano-gTM
Biotin-aRNA Labeling Kit for the Illumina R© System (Epi-
centre, Cat. No. TAN07924) and subsequent amplification,
labeling and hybridization were performed according to Il-
lumina’s whole-genome gene expression direct hybridiza-
tion protocol. Datasets were generated from two biolog-
ical replicates per cell type, which were obtained from a
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pool of three individuals. Samples were pooled using iden-
tical amounts of DNA per donor. Raw data were extracted
with GenomeStudio analysis software (Illumina Inc.) in the
form of GenomeStudio’s Final Report (sample probe pro-
file). RNAwas extracted from two independent sample sets
(one sample at each differentiation step from two different
donors) for quantitative real-time polymerase chain reac-
tion (PCR). cDNA was synthesized from total RNA (1 g)
using the SuperScript II Reverse Transcriptase Kit (Invit-
rogen), following the manufacturer’s instructions. Quanti-
tative real-time PCR (qRT-PCR) was performed with uni-
versal SYBRR© Green PCR Master Mix (Applied Biosys-
tems) on a StepOnePlus Real-Time PCR System. Glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) was used
as housekeeping gene to standardize data, following the
Ctmethod. Primers are described in Supplementary Ta-
ble S1.
DNA extraction, whole-genome methylation profiling and
bisulfite pyrosequencing
DNA methylation was analyzed with Infinium Human-
Methylation450 (HM450) BeadChips (Illumina Inc.). This
array provides genomic coverage of a total of 21 231 UCSC
RefGenes (including the 5′ and 3′ untranslated regions), 26
658 CpG islands (96%), 59 916 DNAse hypersensitive sites
and 80 538 informatically predicted enhancers (25). Total
DNA was extracted with an adenosine triphosphate (ATP)
GenomicDNAMiniKit (ATP Biotech), following theman-
ufacturer’s instructions. Quantification and integrity were
measured with a Qubit R© 2.0 Fluorometer (Life Technolo-
gies) and 1x Tris Acetate-EDTA-agarose gels, respectively.
Starting with 500 ng of good quality total DNA, unmethy-
lated cytosines were converted to uracils using an EZ DNA
MethylationTM Kit (Zymo Research). Subsequently, whole
genome methylation profiles were characterized by am-
plification of converted DNA and hybridization on In-
finium HumanMethylation450 (HM450) BeadChips (Illu-
mina Inc.) following Illumina’s Infinium HD assay methy-
lation protocol. Datasets were generated from two biolog-
ical replicates per cell type, which were obtained from a
pool of three individuals. Samples were pooled using iden-
tical amounts of DNA per donor. Raw data were decoded
with GenomeStudio software (Illumina Inc.) to obtain a
Final Report (sample probe profile). DNA was extracted
from two independent sample sets (one sample at each dif-
ferentiation step from two different donors) for bisulfite
pyrosequencing. Sodium bisulfite modification of 500 ng
DNA was performed with the EZ DNA methylation kit
(D5002, ZymoResearch). Bisulfite pyrosequencingwas per-
formed with the PyroMark Q24 reagents (Qiagen), follow-
ing the manufacturers’ instructions. The PyroMark Assay
Design tool (v. 2.0.01.15) was used to obtain pyrosequenc-
ing oligonucleotides (Supplementary Table S2). After PCR
amplification of the region of interest, methylation levels
were quantified using the PyroMark Q24 system (Biotage).
Statistical analysis
Raw data from GenomeStudio were processed and an-
alyzed in the R statistical computing environment, us-
ing R packages from the Bioconductor project (26)
and SwIMA (Mosen-Ansorena, D and Aransay, AM,
‘Integral analysis and automatic reporting for Illumina
expression/methylation arrays’. Unpublished manuscript).
Using the lumi package (27), raw methylation data
were background-corrected, log2-transformed, quantile-
adjusted for color balance and quantile-normalized. Raw
expression data were background-corrected and log2-
transformed. Then, probes with detection values >0.01 in
all samples were filtered, and the remaining values were
quantile-normalized. Sex chromosomeswere excluded from
the analysis. For methylation sites, annotation of regula-
tion and site location were recorded using Illumina’s Il-
luminaHumanMethylation450k.db package. Methylation
and pairwise expression comparisons were estimated at
each differentiation step. A linear model was fitted to the
data and empirical Bayes-moderated t-statistics were cal-
culated using the limma (28) package. P-values were ad-
justed by determining false discovery rates (FDRs) using
the Benjamini–Hochberg procedure. A site was considered
differentially methylated in a differentiation step for values
of FDR-adjusted P < 0.05 and M-difference (M) > 1.5.
As a reference, differences ofM = 2.0 are equivalent to dif-
ferences of 0.25 in beta values (29). Those probes within the
full-length gene or up to 1500 bp from transcription start
site were annotated as being gene-associated. To reduce
false-positive results from the functional analysis of the
methylation data, the hypergeometric test was used to assess
the enrichment in significant methylation sites within each
gene compared with the number of CpG sites represented
on the BeadChip. For expression data, a gene was consid-
ered to be differentially expressed if at least one of its asso-
ciated probes had a value of FDR-adjusted P < 0.05 and
an >1.5-fold absolute change. Gene ontology (GO) enrich-
ment analysis was performed with theGOstats package and
the DAVID GO web-based tool. Heat maps and CIRCOS
were generated with the gplots and RCircos (30) packages,
respectively. The reactome functional interaction network
was built using Cytoscape software (31). The network was
then exported to Gephi (32), whereupon the Fruchterman–
Reingold clustering algorithm was used to derive the graph
(33). The raw DNA methylation and gene expression data
have been submitted to NCBI Gene Expression Omnibus
under de accession number GSE55112 (http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE55112).
RESULTS
Global methylation analysis during human intrathymic dif-
ferentiation
In order to gain a comprehensive view of DNA methyla-
tion during human  T-cell differentiation we examined
several cell populations isolated ex vivo from the neonatal
human thymus, which represent defined in vivo maturation
stages and focused on four critical developmental check-
points: T-cell commitment (step 1), defined by the transi-
tion from early thymic progenitors with lymphomyeloid po-
tential (CD34+/CD1a−) to T-lineage-restricted progenitors
(CD34+/CD1a+) (2,3); -selection (step 2), which occurs
during the transition from DN CD34+/CD1a+ thymocytes
to DP pre-T-cells expressing Pre-TCR; TCR acquisition
(step 3), which occurs after downregulation of Pre-TCRand
Nucleic Acids Research, 2015, Vol. 43, No. 2 763
gives rise to a substantial population of DP TCR+ cells
and positive selection (step 4), which results in lineage spec-
ification of DP TCR+ thymocytes into either SP CD4+
or SP CD8+ cells (steps 4a and 4b, respectively).
Methylation datasets were generated from two biolog-
ical replicates per cell type (only one in the case of
CD34+/CD1a+), and each biological replicatewas obtained
from a pool of three individuals. To confirm the differentia-
tion sequence, we first used two-dimensional principal com-
ponent analysis (Figure 1A). The observed sequence did
not differ from the expected results, although the Pre-TCR+
and DP TCR+ thymocytes appeared tightly grouped.
Also, the magnitude of the methylation changes between
DP TCR+ and SP CD4+ (step 4a) or SP CD8+ (step 4b)
cells was much greater than between the two SP popula-
tions, suggesting that steps 4a and 4b share many differen-
tially methylated regions (DMRs). Hierarchical clustering
correctly grouped all biological replicates and confirmed the
differentiation sequences (Supplementary Figure S2).
To identify DMRs, we selected CpG sites with an M-
difference (M) > 1.5 and an adjusted value of P < 0.05
at each differentiation step. Using these criteria, we anno-
tated 3804 unique DMRs within the entire differentiation
process (Supplementary Table S3), although they were un-
evenly distributed, from only 57 DMRs (step 3) to 1692
DMRs (step 4a) (Figure 1B). Despite the large scale of
the methylation changes, most differentiation steps shared
a very small amount of DMRs, suggesting that methyla-
tion changes are mostly unique events during thymocyte
differentiation. Only steps 4a and b shared a significant
amount of DMRs (>50%), mirroring the phenotypic prox-
imity demonstrated by the principal component analysis.
This was also observed in the genome-wide representation
of the methylation data, which all had a unique genomic
distribution of DMRs at each differentiation step, except
for the remarkably similar 4a and 4b steps (Figure 1C).
We observed both gain (de novo-methylated DMRs) and
loss (demethylated DMRs) of methylation during thymo-
cyte differentiation. Nevertheless, scatter plots for each dif-
ferentiation step showed thatDNAdemethylation prevailed
over de novo methylation in all differentiation stages, with
the sole exception of the earliest differentiation step: from
CD34+/CD1a− to CD34+/CD1a+ cells (step 1) (Figure
2A). In fact, most DMRs underwent demethylation events
during T-cell maturation that were mostly concentrated at
the -selection stage (step 2) and at the transition from DP
TCR + to SP CD8+ or SP CD4+ (steps 4a and 4b, respec-
tively). Overall, we annotated 3826 demethylation versus
1167 de novomethylation events during thymocyte differen-
tiation, implying that DNA demethylation is the dominant
mechanism (Figure 2B), at least within the genomic cover-
age of theHM450BeadChip. These changes weremostly lo-
cated outside CpG islands and in gene body regions (Figure
2C). In addition, DNAmethylation changes at CpG islands
were found at higher frequencies during early T-cell com-
mitment (step 1) than at subsequent differentiation steps.
Changes in DNA methylation are mostly unique and irre-
versible events during thymocyte differentiation
Box plots with the M-values of all demethylated and
de novo-methylated thymic DMRs showed that DNA
demethylation was progressive throughout differentiation
(Figure 3A), indicating that loss ofmethylation is not gener-
ally reverted.M-values between intrathymic CD8 and CD4
SP populations are very similar as both populations share
a significant proportion of their DMRs. On the other hand,
M-values of de novo methylation DMRs increased only at
the earliest developmental transition, and remained stable
in subsequent differentiation steps.
Heat maps with all DMRs at each differentiation
step confirmed that the demethylated and the de novo-
methylated CpG sites remained stable in subsequent dif-
ferentiation steps without reversion of the methylation sta-
tus (Figure 3B). A similar result was observed when DMRs
were grouped by behavior during differentiation byK-mean
clustering (Figure 3C). Instead of a progressive loss or gain
of methylation, once a DMR had undergone a methyla-
tion change it generally remained unchanged at subsequent
stages or changed only mildly. For instance, as shown in
Figure 3C, clusters 4, 8 and 17 showed a gain of methyla-
tion at step 1 and afterwards the centroid of the cluster re-
mained flat. Also, DMRs in clusters 13 and 29 experienced
an abrupt loss of methylation during -selection that was
maintained during the DP and SP stages. A few clusters,
such as 20 and 22, showed a progressive loss of methyla-
tion during two consecutive differentiation steps, and some
others, such as 1 and 2, showed almost flat centroids due
to the clustering of those DMRs with less marked changes.
Nevertheless, none of the cluster centroids presented a tran-
sient peak at any intermediate differentiation step. Together,
these results indicate that demethylation and de novomethy-
lation are generally not continuous processes, but rather
unique and irreversible events that occur at specific points
during thymocyte maturation.
DNAmethylation changes during  T-cell development are
strongly associated with T-cell differentiation and TCR func-
tion
We found 3804 probes that were differentially methylated
during T-cell development in the thymus, corresponding to
1760 genes (Supplementary Table S3). The HM450 array
contains an average of 17 CpG sites per gene region, so we
assessed the enrichment of DMRs within each gene by hy-
pergeometric testing (see ‘Materials andMethods‘). By this
means, we annotated 457 highly significant genes that were
differentially methylated during T-cell development, cor-
responding to 1642 probes (Supplementary Table S4). Of
these, only 95 genes contained one ormore hypermethylated
probes and only 11 genes (RAG1, RAG2, CD8A, CD1A,
PTCRA, OSBPL5, ZP1, CBFA2T3, AXIN2, ARPP21 and
BCL11B) showed reversion of the methylation changes ac-
cumulated at a previous differentiation stage. GO analy-
sis revealed that differentially methylated genes were essen-
tially involved in the immune function (Figure 4A), includ-
ing hematopoiesis, T-cell differentiation and antigen pro-
cessing and presentation. However, the distribution of these
functional categories during T-cell differentiation was not
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Figure 1. Overview of DNA methylation during thymocyte maturation. (A) Principal component analysis of all samples based on methylation profiles
obtained from HM450 arrays. Arrows represent the direction of differentiation. (B) Venn diagrams showing all annotated DMRs at each differentiation
step. (C) Genomic distribution of the thymic DMRs at each differentiation step using CIRCOS. Colored bars represent the M-value. The gray lines
intersect at M = 0.
homogenous. Steps 2 and 4a/4b were the most highly en-
riched for hematopoiesis-related genes, while step 1 showed
a preferential enrichment of antigen processing and presen-
tation and cell-adhesion categories (Supplementary Table
S5). Additionally, step 3 did not show any significant en-
richment of anyGO category, further supporting the notion
that the transition from -selected pre-T-cells to  TCR+
cells is unremarkable at the DNA methylation level.
Generation of a functional protein interaction network
involving all highly significant differentially methylated
genes showed an intricate interconnected grid, which indi-
cates a strong functional connection between the annotated
genes (Figure 4B). A centered cluster of genes associated
with TCR function was clearly observed. This included the
CD3 complex, the CD8A and CD28 molecules, and many
genes involved in TCR signaling, such as the lymphocyte-
specific protein tyrosine kinase (LCK), the FYN binding
protein (FYB) and the IL2-inducible T-cell kinase (ITK).
Another gene cluster was observed around the integrin beta
2 (ITGB2) that included genes involved in cell adhesion (IT-
GAE, ITGAX), cytoskeleton (ACTN3,ACTN1,CORO1A),
extracellular matrix (LAMA3, COL8A1) and intracellular
signaling associatedwith these processes (PTK2B,PRKCH,
CTNND,RASSF5). We also overlapped the T-cell differen-
tiation signature (GeneWeaver,GO:0030217) with theDNA
methylation profile at each differentiation step (Figure 4C).
We observed that most differentially methylated genes in
this signature became demethylated during maturation, fol-
lowing the global demethylation trend in the thymus. -
selection (step 2) was associatedwith one of themost promi-
nent demethylation waves in thymocyte maturation, which
affected 16 known components of the T-cell differentia-
tion program, including some of the most essential pre-
TCR/TCR components and some associated signaling pro-
teins (ITK, PIK3CD, THEMIS). Additionally, RAG1, the
mutagenic DNA nucleotidylexotransferase (DNTT) and
the pre-T-cell antigen receptor  (PTCRA) were demethy-
lated at this point, suggesting thatDNAdemethylation con-
tributes to the generation of a functional pre-TCR complex.
The transition from -selected thymocytes expressing a
functional pre-TCR to DP thymocytes expressing the ma-
ture  TCR (step 3) was not associated with changes
in any gene in the TCR differentiation signature. In con-
trast, the transition from DP TCR /+ to SPCD4+ or
SPCD8+ thymocytes (steps 4a and b), which marks the pos-
itive selection process, is associated with the most notice-
able DNA demethylation wave during thymocyte develop-
ment. Most of the genes included in the T-cell differentia-
tion signature underwent demethylation andwere shared by
SP CD4+ and SP CD8+ cells, although a few interesting di-
vergences were detected. Of these, CD28 was demethylated
in the CD4+ lineage, while CD8A and LCK were specifi-
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Figure 2. Demethylation and de novo methylation during thymocyte differentiation. (A) Scatter plots of all annotated DMRs at each differentiation step.
(B) Volcano plot showing all probes demethylated (blue) and de novo-methylated (red) during differentiation. (C) Distribution of thymic DMRs according
to CpG content and gene location. Shores were defined as the region 2 kb upstream and downstream of a CpG island and shelves as the 2 kb region outside
of a shore.
cally demethylated in the CD8+ lineage. It is worth noting
that CD8A had unusual DNA methylation dynamics, since
it was demethylated at the -selection checkpoint, but sub-
sequently remethylated in the SP CD4+ lineage. Only two
other genes in the T-cell differentiation signature, PTCRA
and RAG1, showed remethylation after demethylation, in-
dicating that remethylation events may be restricted to just
a few key genes.
On the whole, we found that DMRs were highly enriched
in the T-cell differentiation signature but were not restricted
to it. Some differentially methylated genes are involved in
other biological functions such as apoptosis (TNFAIP8,
FASL) or cell adhesion (ITGAE, ITGAX). Up to 88 genes
that encode transcriptional regulators were differentially
methylated, many of them with an as yet unknown func-
tion in the T-cell differentiation context (HOXA6, FOXK1,
VOPP1, TOX2, etc.) (Table 1). We also found transcrip-
tional regulators that were differentially methylated be-
tween the CD4+ and CD8+ lineages, and which are well
known effectors during the process of CD4 versus CD8
lineage commitment. These included the zinc finger and
BTB domain containing 7B (ZBTB7B), the thymocyte
selection-associated high-mobility group box (TOX) and
RUNX3, and some other genes that had not previously
been reported, such as the arginine-glutamic acid dipeptide
(RE) repeats (RERE) and the additional sex comb-like 1
(ASXL1).
Gene expression dynamics in T-cell differentiation
To study the association between DNA methylation and
the transcriptional program encompassing thymocyte de-
velopment, we analyzed RNA expression at each partic-
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Figure 3. DNA methylation dynamics during differentiation. (A) Box plots showingM-values of demethylated and de novo-methylated DMRs. Each box
plot represents de M-value distribution of all annotated thymic DMRs at each differentiation step. (B) Heat maps showing methylation values of all
demethylated DMRs at each differentiation step and in all cell samples. DMRs at each differentiation step are grouped together to allow visualization of
the methylation status at subsequent stages. (C) K-means clusters of all thymic DMRs during differentiation (cluster centroid; black line).
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Figure 4. Functional analysis of thymic DMRs. (A) GO analysis of all thymic DMRs. The frequencies of genes in each category are indicated (P < 0.01).
(B) Reactome functional interaction network of DMR-enriched genes. Network centrality is indicated by a color scale. (C) Volcano plots with overlapping
M-values of all microarray probes (black dots) in each differentiation step with only those associated with genes in the T-cell differentiation signature
(orange dots).
ular thymic differentiation step. Gene expression datasets
were generated from two biological replicates per cell type,
which were obtained from a pool of three individuals. Up
to 4465 unique probes corresponding to 3803 differentially
expressed genes (DEGs) were annotated during differenti-
ation (>1.5-fold change) (Supplementary Table S6). Prin-
cipal component analysis showed a similar sample distri-
bution to that of DNA methylation. Nonetheless, the Pre-
TCR+ and DP TCR+ thymocytes were not as tightly
grouped (Supplementary Figure S3), indicating that both
cell subsets have their own gene expression program, even
in the absence of significant DNA methylation changes.
Most DEGs were accumulated at steps 2, 4a and b (Fig-
ure 5A) but, in contrast to DMRs, we found no specific bias
toward either upregulation (2961 probes) or downregula-
tion (2792 probes). In addition, global gene expression dy-
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Table 1. Transcriptional modulators differentially methylated during thymic differentiation
Differentiation step Gene (official gene symbol)
Step 1 BCL11Ba, FOXK1a, HOXA6a, LHX6, PRDM8a, TFCP2 and ZNF135a.
Step 2 AHRR, BCL11B, CBFA2T3, HDAC4, IKZF1, JMJD6, MSI2, RAG1,
RORC, SMARCA4, SMARCB1, TBL1XR1, TCF7, TNRC6B and TULP4.
Step 3 AFF3, CDC73, RCOR3, VOPP1, ZNF691a and ZNF707a.
Step 4a and 4b ACTB, AIRE, BACH2, BCL11B, EIF2C2, ETS1, HIPK2, LBH, MAFGa,
PASK, RAG1a, RORC, SATB1, SMYD1, STAT1, TNRC6B, TOX2,
ZFP36L1, ZNF217, ZNF238 and APBB1.
Step 4a only MYST4, PRDM1, SP3, SP4, ATF7IP, RERE, ASH1L, CREM,
CBFA2T3a, FOXK1, LEF1, SSBP2, ZBTB7B, ASCC1, ASXL1,
CTNND1a, DNMT3A, DPF2, LMO2a, SSBP2, STOX2, TOX, ZCCHC11
and ZNF589.
Step 4b only CBL, KLF13, SMAD3, FOXP1, NFATC1, RUNX3, SND1, TRERF1,
TBL1XR1, SKI, ZHX2, BCL9L, C14orf43, PHRF1 and PNRC1.
aDe novo-methylated genes.
namics during thymocyte differentiation behaved quite dif-
ferently from DNA methylation, as many differentially ex-
pressed probes were shared between two or more differen-
tiation steps (Figure 5A), while DMRs were mainly stage-
specific (Figure 1B). This suggested that gene expression
changes occur progressively during thymocyte differentia-
tion. To test this hypothesis, we applied K-means cluster-
ing to all DEGs (Figure 5B). In contrast to DMR clusters,
many of the resulting DEG clusters presented progressive
changes during consecutive differentiation steps and mini-
mum or maximum values at intermediate stages. DEG clus-
ters included many genes known to be involved in thymic
differentiation. For instance, clusters 18 and 26 showed a
progressive increase in expression until SP CD4+ and SP
CD8+ stages and included many genes related to TCR and
T-cell response, such as IL32, CD27, LAT, ITK, CCR7
and FYB. Cluster 20 exhibited the opposite trend, and in-
cludedmany genes of the B-cell andmyeloid developmental
program, such as LAT2, VPREB1, IGLL1, NCF4, EMR2,
CTSG, PLEK and LYN, and early differentiation mark-
ers such as CD34. Other clusters (6, 13, 16, 19 and 27)
showed maximal expression levels in Pre-TCR+ and DP
TCR+ cells, their expression decreasing at downstream
SP CD4+/CD8+ stages. This was the case for cluster 16,
which contained some key genes of the T-cell developmen-
tal program andTCR signaling includingRORC,NFATC3,
CD8A andCD8B, and others with an as yet unknown func-
tion in this process (VOPP1, ARPP-21, RASD1, MAFB,
etc.). The remaining clusters showed very different kinetics
during T-cell maturation but none of them showed strong
asymmetry between CD4+ and CD8+ SP stages. In fact,
although positive selection of SP CD4+/CD8+ thymocytes
(steps 4a/4b) accounted for most of the expression changes
occurring during T-cell development, the two populations
shared over 70% of the annotated changes. This finding in-
dicates that CD4+ andCD8+ SP thymocytes are remarkably
similar and also explains the presence of the almost flat cen-
troids between the two cell types in the K-means clusters.
Despite these similarities, we found that important genes
were differentially expressed between the populations (Fig-
ure 5C). For instance, many cytotoxicity-associated genes
were exclusively upregulated in SP CD8+ cells (CTSW,
GZMK, PRF1 and FGFBP2), and also the recently de-
scribed transcription factor in mouse NKT cells (ZNF683)
(34,35), which is a homolog of Blimp-1 that greatly in-
creased its expression (>7-fold change) in SP CD8+ cells.
Conversely, some genes were only upregulated in SP CD4+
cells, such as cathepsin L1 (CTSL1), which is involved in
protein recycling within the lysosome and the maturation
of the MHC class II complex, the chemokine (C-C Motif)
receptor 4 (CCR4) and ZBTB7B.
Recent reports have provided very detailed measures
of gene expression throughout mouse T-cell differentia-
tion, providing a new opportunity to compare regulatory
networks between mouse and human T-cell development
programs (12,13). Indeed, our analysis of human thymo-
cytes identified many common elements with mouse coun-
terparts. During early T-cell lineage commitment, repres-
sion of many progenitor cell genes in mouse is also ob-
served in human thymocytes. The shutdown of the pro-
genitor and non T-cell programs in both mouse and hu-
man cells involves a number of transcriptional regulators,
such as HHEX, LYL1, SPI1, NFE2, MYCN, LMO2 and
several interferon regulatory factors (IRF) (13). Another
interesting finding from the initial steps of differentiation
is the differential expression of four diacylglycerol (DAG)
kinases (DGKA, DGKE, DGKD and DGKQ), which is
similar to previous observations in mouse thymocytes, sug-
gesting that the function of this family of proteins is con-
served during T-cell development (12). Later in differen-
tiation, human thymocytes share many elements within
the Notch signaling pathway, including upregulation of
NOTCH-induced genes such as TCF7 and BLC11b during
-selection, whose expression is subsequentlymaintained at
a high level and c-MYC, which is only transiently overex-
pressed upon -selection. Overall, the transcriptional pro-
gram induced by -selection is similar in mouse and human
thymocytes and includes transient activation of NOTCH
signaling and expression of TCR-associated components
(CD3 complex, PTCRA, ITK, FYB, RORC, etc.). Corre-
spondingly, positive selection in mouse and human includes
TCR signaling components and transcriptional regulators
as a consequence of TCR signaling of the newly rearranged
 TCR. Similarly to what occurs in mice, we observed
upregulation of canonical TCR transcriptional regulators
(EGR2, FOS,RELB,NFKB1 andNFKB2), and some neg-
ative selection-associated genes (PDCD1 and GADD45B).
Also, human data confirmed the upregulation of some in-
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Figure 5. Gene expression changes during differentiation. (A) Venn diagrams showing the number of probes differentially expressed at each differentiation
step. (B) K-means clustering of thymic DEGs during T-cell differentiation (cluster centroid; black line) and heat maps of representative K-means clusters.
(C) Gene expression changes during differentiation of CD4+ and CD8+ lineages. Comparison of gene expression changes in SP CD4+ cells (horizontal
axis) and SP CD8+ cells (vertical axis) versus DP cells.
hibitory molecules (ID2 and ID3) and the downregulation
of TCF12, previously observed during mouse positive se-
lection (12). Finally, differentiation of CD4+ and CD8+ lin-
eages seems to be highly conserved in both humans and
mice, including, as expected, many cytotoxicity-associated
genes and transcriptional regulators (EOMES, ZBTB7B
andRUNX3), which further emphasizes the transcriptional
similarity between human and mouse regulatory networks.
Overall, these results highlight the importance of studying
mouse T-cell differentiation for the valuable insights into
human development it provides.
DNAmethylation is associated with gene expression changes
during  T-cell differentiation
We next investigated whether, as expected, DNA methy-
lation and gene expression levels are inversely correlated
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throughout human thymopoiesis. Among the 4993 DNA
methylation changes found during thymic differentiation
(M > 1.5), 768 (around 15.4%) were inversely corre-
lated with the RNA expression of their associated genes
(>1.5-fold change) at a concurrent differentiation step (Fig-
ure 6A). Most of these inverse correlations corresponded
to demethylation events associated with upregulated genes
(670 probes), which suggests a more prominent role of
demethylation in gene expression.
Given that only 15.4% of the methylation changes de-
tected were inversely correlated with gene expression, it is
possible that the other DMRsmay affect gene expression at
downstream differentiation steps or may not be related to
gene expression at all. Indeed, we found 113 demethylated
probes that are only associated to gene expression upregu-
lation at downstream differentiation steps (Supplementary
Table S8). This suggests that some genes, such asDGKD and
PDCD1 (Figure 6B), could be demethylated to allow sub-
sequent expression in response to forthcoming regulatory
events, as reported in previous studies (36).
To investigate howDNAmethylation may affect gene ex-
pression in human thymopoiesis, we classified all DMRs as-
sociated with gene expression changes according to their
gene location and CpG density. We found that shelf and
non-CpG islands were the most significantly enriched cate-
gories (P < 10−13 and P < 10−16, respectively), while CpG
islands were almost entirely excluded (P < 10−16) (Figure
6C).With respect to gene location, no significantly enriched
category was observed. Collectively, these results indicate
that DMRs associated with gene expression changes are
mostly concentrated in CpG-poor regions.
GO enrichment analysis of DEGs showed that cell cy-
cle was the most enriched functional category (Supplemen-
tary Figure S4A), while the set of DMRs was far more
enriched in hematopoiesis-related genes. By contrast, GO
enrichment analysis considering only those genes with in-
versely correlated gene expression and DNA methylation
showed preferential enrichment of immune response and
leukocyte activation-related genes (Supplementary Figure
S4B). Cell cycle-relatedGOcategories were absent and thus,
although many cell cycle genes were differentially expressed
during T-cell differentiation, they did not appear to be
significantly regulated by DNA methylation. Importantly,
KEGG (Kyoto Encyclopedia of Genes and Genomes) en-
richment analysis of these genes identified the TCR sig-
naling pathway as the most prominent functional pathway
regulated by DNA methylation (FDR, P < 10−6) (Supple-
mentary Figure S4C). This category included many essen-
tial genes associated with TCR function, such as PTPRC,
ITK, CD3G, CD3D, CD8A, CD247, PIK3CD, NFKBIA,
PDCD1, FYB, CD28, NFATC1, etc., most of which were
demethylated and upregulated during -selection and SP
CD4+/CD8+ specification. As an example, genes encod-
ing the CD3 complex components (CD3D, CD3G, CD3E
and CD247), and also some essential TCR signaling ele-
ments such as ITK, were demethylated and overexpressed
during the transition from CD34+/CD1a+ to pre-TCR+
cells (Figure 6B and Supplementary Figure S5). The SLP76-
associated phosphoprotein, known as FYB, was likewise
overexpressed and demethylated at the -selection check-
point, while SLP76 demethylation and overexpression oc-
curred at the downstream SP stage. Thus, DNA demethy-
lation seems to affect TCR function at different points dur-
ingT-cell differentiation, which probably help tune the TCR
signaling.
Other signaling pathways known to be essential in thy-
mopoiesis were not so clearly affected by DNA methy-
lation. Particularly, of the 137 annotated genes associ-
ated with the NOTCH signaling pathway (GO:0007219,
GeneWeaver), which is essential for inducing T-cell com-
mitment and development, 33 underwent significant gene
expression changes (>1.5-fold change) between particu-
lar differentiation stages (Supplementary Figure S6), but
only downregulation of the nuclear receptor corepressor
2 (NCOR2), the arrestin  1 (ARRB1) and the cyclin-
dependent kinase 6 (CDK6) were associated with DNA
methylation changes. In addition to NOTCH signaling,
shutdown of the non-T-cell lineage regulatory programs
is essential for T-cell lineage commitment (8). Indeed, we
found downregulation of many essential key factors of the
myeloid and B-cell differentiation program during the tran-
sition from CD34+/CD1a− to CD34+/CD1a+ cells (step
1), including genes encoding the spleen focus-forming virus
proviral integration oncogene 1 (SPI1), the Spi-B tran-
scription factor (SPIB), CCAAT/enhancer binding protein
(C/EBP)  (CEBPA), the feline sarcoma oncogene (FES),
the v-Rel avian reticuloendotheliosis viral oncogene ho-
molog B (RELB) and tescalcin (TESC). None of these was
associated with de novo methylation events.
Methylation changes were also noted in many essen-
tial genes exclusively associated with the DP to SP transi-
tion, such as the inositol (1,4,5) trisphosphate 3-kinase B
(ITPKB) gene, which is known to be involved in positive
selection (37). Accordingly, this gene was demethylated and
upregulated at the SP CD4+/CD8+ specification stage (Fig-
ure 6B and Supplementary Figure S5). We also found some
genes that were exclusively demethylated either in the CD4+
or in the CD8+ lineage, such as ZBTB7B, which was specif-
ically demethylated and overexpressed in SP CD4+ cells.
We also found a few genes that showed more complex
regulation kinetics with concurrent silencing and remethy-
lation events. These included theRAG locus, which is specif-
ically demethylated and upregulated in -selected thymo-
cytes and then remethylated and silenced after positive se-
lection, during the transition from DP TCR+ to SP
CD8+ and CD4+ cells. Following the same pattern, CD8A
was also demethylated and overexpressed in pre-TCR+ thy-
mocytes but, expectedly, remethylation was only observed
in the SP CD4+ subset (Figure 6B and Supplementary Fig-
ure S5). In contrast, SP CD8+ cells underwent an addi-
tional demethylation event in two CpG sites at an intronic
region of the CD8A gene, suggesting that complex regu-
latory mechanisms control lineage-specific DNA methyla-
tion. Epigenetic silencing by remethylation of previously
demethylated genes was not a common regulatory mecha-
nism during human T-cell development, but was restricted
to a very small subset of genes that also included the
gene encoding the CD1a molecule (CD1A); the CAMP-
regulated phosphoprotein of the 21 kDa gene (ARPP21);
the pre-T-cell antigen receptor alpha gene (PTCRA) and the
oxysterol binding protein-like 5 gene (OSBPL5). However,
most of the genes repressed during the DP/SP transition
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Figure 6. Association of DNA methylation and gene expression. (A) Correlation between DMRs and expression of their associated genes. Each bar
represents the number of DMRs associated with gene expression changes (FC > 1.5) at a concurrent differentiation step. (+) indicates de novomethylation
or gene expression upregulation. (−) represents demethylation or gene expression downregulation. (B) DNA methylation and gene expression kinetics of
representative genes during T-cell differentiation. To aid visualization of expression and methylation data in all differentiation stages, CD4+ and CD8+
cells are represented as consecutive samples. Black dots indicate differentially methylated CpG sites associated with each gene. The transcription start site
(TSS) is indicated by an arrow. (C) Distribution of thymic DMRs associated with changes in gene expression, according to CpG content and gene location.
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(TCF7, NFATC3, RORC, etc.) experienced no associated
DNA remethylation event.
DISCUSSION
Genome-wide methylation and gene-expression studies
comparing multipotent hematopoietic stem/progenitor
cells with terminally differentiated lineage-restricted cells
have provided evidence of the magnitude of DNA methy-
lation and gene expression changes during the process of
hematopoiesis (15,38,39). To evaluate the contribution of
these changes to the particular developmental program
of T-cells, we have performed a more systematic analy-
sis of individual maturation stages within the human T-
cell lineage and shown that DNA methylation is deeply
modulated during the T-cell differentiation process that
occurs in the postnatal human thymus. We found that
DNA methylation changes in a particular CpG site take
place generally only once during development and are then
stable in subsequent differentiation stages. These changes
consist of demethylation and de novo methylation events,
which occur throughout the entire differentiation process,
although de novo methylation is mostly restricted to the
T-cell commitment stage (step 1). This result is in agree-
ment with the reported role of DNA methyltransferase
3a (DNMT3a) during hematopoietic stem cell differenti-
ation, which seems to be required for epigenetic silencing
of some stem cell-specific genes (40). Nonetheless, de novo
methylation was poorly correlated with gene repression.
In fact, we observed that many important hematopoiesis-
related genes known to be repressed during mouse T-cell
commitment (13) are also downregulated during the tran-
sition from CD34+/CD1a− to CD34+/CD1a+ human thy-
mocytes (LYL1, HHEX, NFE2, MYCN, LMO2, CEBPA,
SPI1, etc.), although these changes are not associated with
de novo methylation events. This raises the question of how
de novomethylation contributes to the T-cell differentiation
program and, particularly, to T-cell specification and com-
mitment. A likely explanation is that de novo methylation
does not work as a direct regulatory mechanism of gene ex-
pression, but might reinforce other repressing mechanisms
that are already in place. De novo methylation preceded by
gene repression has been well documented in some experi-
mental settings, such as the silencing of retroviral sequences
during embryonic development, X chromosome inactiva-
tion and the silencing of the imprinted IGF2R gene (41–46).
Our results also revealed delayed kinetics associated with
de novo DNA methylation. For instance, the LIM domain
only 2 protein (LMO2), which is essential during erythroid
development, is repressed during early T-cell specification
and -selection, but is methylated de novo at the down-
stream SP stages. Similarly, the immunoglobulin lambda-
like polypeptide (IGLL) gene, which encodes one of the sur-
rogate light-chain subunits of the Pre-B-cell receptor, as well
as the pleckstrin (PLEK) gene, which encodes the major
Protein kinase C (PKC) substrate in platelets and is involved
in phagosome maturation in macrophages, are both down-
regulated early in development during T-cell commitment,
but are not methylated until the -selection checkpoint.
Therefore, de novomethylation of these genes cannot act as
the major driver of hematopoietic potential restriction dur-
ing thymopoiesis, but instead could help fix T-cell commit-
ment at later stages of development. It is also important to
emphasize that epigenetic silencing of previously repressed
loci is unlikely to be exclusively mediated by DNAmethyla-
tion, as delayed histone marking also occurs during mouse
thymocyte differentiation (13), and thus several repressive
epigenetic mechanisms may coincide to ensure strong and
irreversible repression. Alternatively, de novo methylation
events could represent not only a gain of 5-methylcytosine
(5mC) but also of 5-hydroxymethycytosine (5hmC), since
analysis methods based on bisulfite DNAmodification can-
not distinguish the two epigenetic marks. In a very recent
report, 5hmC was studied in different mouse T-cell subsets,
including two intrathymic populations (DP and SP stages)
(47). Although this epigenetic mark constitutes <1% of to-
tal CpG methylation in the thymus (48), it was found to
be enriched in highly transcribed genes and enhancer re-
gions (47), suggesting a regulatory role in T-cell differenti-
ation. Thus, a proportion of the de novomethylation events
noted in our study could be associated with active transcrip-
tion rather than epigenetic silencing. Nonetheless, 5hmC
and 5mCwere not simultaneously studied, so we cannot tell
whether 5hmC marked an active demethylation process or
rather acted as a unique and stable epigenetic mark with its
own regulatory function. Future studies will help to clarify
the role of 5hmC during T-cell lineage specification.
We foundDNAdemethylation to bemuchmore frequent
than de novo methylation and to be highly correlated with
transcriptional activation during thymocyte differentiation.
This trend of demethylation has been noted before in the
hematopoietic compartment when comparing hematopoi-
etic stem cells with terminally differentiated cells (38) and,
in a more detailed study, the prevalence of demethylation
over de novo methylation was clearly demonstrated during
B lymphopoiesis (49). In human thymocyte maturation, we
observed that DNA demethylation affects the expression
of many essential genes associated with the T-cell develop-
mental program, but of particular note is the enrichment
on TCR-related genes among thymic DMRs. In addition
to TCR function genes, we found key developmental genes
whose expression is associated with demethylation, such as
RORC,CCR7,TCF7,RUNX3, IKAROS, etc. However, the
lack of association between DMRs and specific signaling
pathways that are essential for T-cell development, such as
theNOTCHpathway, is surprising, although it could be be-
cause this pathway has a broad developmental role that is
not restricted to T-cells.
An important aspect of our results is that DNA methy-
lation appears to contribute to the decision about alterna-
tive CD4+ versus CD8+ lineage exclusion during the posi-
tive selection process. However, we found CD8+ and CD4+
intrathymic lineages to be very similar at the transcrip-
tional level, in line with previous transcriptome analysis in
mouse and human cells (6,12). This similarity was also ev-
ident in the methylome, although we identified DMRs that
were associatedwith some transcriptional regulators known
to be involved in the CD4 versus CD8 cell fat decision
(ZBTB7B, RUNX3, TOX) (50,51) and with potential new
candidates, such as ASXL1 and RERE. This suggests that
we may not yet have identified all the functional genes regu-
lated at this developmental checkpoint. On the other hand,
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CD4 was previously reported to be epigenetically silenced
in the CD8+ lineage, but we did not observe any de novo-
methylated region associated with this gene. There may be
DMRs in the CD4 gene that are not covered by the HM450
array. Nonetheless, it has been reported that epigenetic si-
lencing of CD4 is not affected by the inhibition of DNA
methylation, suggesting that other mechanisms may be in-
volved (52).
Another significant aspect of DNA methylation kinet-
ics is that they are typically unidirectional, i.e., the newly
acquired methylation status in most regions that accumu-
late methylation changes is not reversed. Notably, most hy-
permethylation events are concentrated at the early T-cell-
specification stage, but we found a poor correlation with
gene expression. Taken together, these observations imply
that most genes that achieve transient maximum expres-
sion at intermediates stages of the differentiation process are
silenced by a DNA methylation-independent mechanism.
Nevertheless, we identified a few genes that, after demethy-
lation, underwent remethylation and repression in a sub-
sequent stage of differentiation (RAG1, RAG2, PTCRA,
CD8A, CD1a, ARPP21 and OSBPL5). Interestingly, some
of these genes are essential during T-cell development, but
need to be efficiently shutdown to ensure proper matu-
ration. Indeed, repression of RAG1 and RAG2 is critical
for ensuring allelic exclusion and T-cell clonality. Also,
PTCRA, encoding the pre-T surrogate chain, needs to be
silenced after TCRB rearrangement to allow for a tran-
sient pre-TCR expression and its subsequent replacement
by the mature  TCR and CD8A gene must be repressed
in CD4+ cells to avoid MHC class I binding. Consequently,
the remethylation events observed in these genes probably
reflect a critical requirement for irreversible epigenetic si-
lencing.
In summary, mapping DMRs during T-cell differentia-
tion has yielded a large catalogue of novel cis- and trans-
regulatory elements that will give us further insight into the
biological significance of epigenetic regulation during devel-
opment. Our results show howDNAmethylation dynamics
are linked with transcriptome networks during thymocyte
differentiation and reveal that these changes are mostly ir-
reversible demethylation events often associated with gene
expression. In this context, the intuitive notion that epi-
genetic silencing might drive lineage restriction during T-
cell development may be deceptive; rather, it appears that
DNA demethylation of lineage-specific genes allows pro-
gression during differentiation, and so works as an induc-
tive mechanism, while de novomethylation is mostly an aux-
iliary mechanism in thymopoiesis. The specific interaction
of these DMRs with other epigenetic marks and transcrip-
tional modulators needs to be clarified in further studies in
order to complete our picture of the molecular mechanisms
underlying T-cell commitment and differentiation in the hu-
man thymus.
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